{'fraction_non_alphanumeric': 0.01603206412825651, 'fraction_numerical': 0.0, 'mean_word_length': 5.666666666666667, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
A global measure to assess switching antipsychotic medications in the treatment of schizophrenia

It is common practice to switch antipsychotic medications in the treatment of patients with schizophrenia to enhance clinical efficacy and/or reduce drug‐related side effects. The conventional Clinical Global Impression (CGI) of severity scale is a well‐understood measure to track switching effects but does not differentiate between the severity of clinical symptoms and the impact of side effects..